Knowledge Center

Patent / Jun 29, 2017

Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition

Authors:
  • Mohammad Salman
  • Arturo Angel
  • Vijaya Swaminathan
  • George Magrath
Source:
US 20170182071 A1 20170629

The invention relates to a topical suspension formulation that includes a tetracycline, a liq. medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liq. medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 μ.

Also in the Knowledge Center

Related Content

Continuous Flow

Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.

Page
Read more

High value applications

ËÄÉ«AV provides off-patent APIs that can be used with confidence where the choice of active ingredient is critical.

Page
Read more

Drug Substance Manufacturing

We have an exceptional range of flexible manufacturing equipment to ensure availability and suitability for our customers’ manufacturing needs.

Page
Read more